Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 15, 2015 - Issue sup1: Proceedings of the Fourth International Symposium on Thymosins in Health and Disease
Submit an article Journal homepage
2,647
Views
8
CrossRef citations to date
0
Altmetric
Editorial

A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection – first announcement of the protocol

Shuang-Jian QiuZhongshan hospital and Fudan University, Liver Cancer Institute, Fenglin Road 180, Shanghai, China+86 21 6404 1990; [email protected]
,
Zhong-Guo ZhouSun Yat-Sen University Cancer Center, Guangzhou, China
,
Feng ShenSecond Military Medical University, Eastern Hepatobiliary Surgery Hospital, Shanghai, China
,
Ai-Jun LiSecond Military Medical University, Eastern Hepatobiliary Surgery Hospital, Shanghai, China
,
Min-Shan ChenSun Yat-Sen University Cancer Center, Guangzhou, China
,
Min-Gang YingFu Jian Provincial Cancer Hospital, Fuzhou, China
,
Zhong ChenAffliated hospital of Nantong University, Nantong, China
,
Yi-Xin ZhangNantong Tumor Hospital, Nantong, China
,
Hui-Chuan SunZhongshan hospital and Fudan University, Liver Cancer Institute, Fenglin Road 180, Shanghai, China+86 21 6404 1990; [email protected]
&
Jia FanZhongshan hospital and Fudan University, Liver Cancer Institute, Fenglin Road 180, Shanghai, China+86 21 6404 1990; [email protected]
 show all
Pages 133-137 | Published online: 22 Jun 2015

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Francesca Pica, Roberta Gaziano, Ida Antonia Casalinuovo, Gabriella Moroni, Cristina Buè, Dolores Limongi, Cartesio D’Agostini, Carlo Tomino, Roberto Perricone, Anna Teresa Palamara, Paola Sinibaldi Vallebona & Enrico Garaci. (2018) Serum thymosin alpha 1 levels in normal and pathological conditions. Expert Opinion on Biological Therapy 18:sup1, pages 13-21.
Read now
Xiaoning Wu, Yiwen Shi, Jialing Zhou, Yameng Sun, Hongxin Piao, Wei Jiang, Anlin Ma, Yongpeng Chen, Mingyi Xu, Wen Xie, Jun Cheng, Shibin Xie, Jia Shang, Jilin Cheng, Qing Xie, Huiguo Ding, Xuqing Zhang, Lang Bai, Mingxiang Zhang, Bingqiong Wang, Shuyan Chen, Hong Ma, Xiaojuan Ou, Jidong Jia & Hong You. (2018) Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study. Expert Opinion on Biological Therapy 18:sup1, pages 61-69.
Read now

Articles from other publishers (6)

Nana Tao, Xie Xu, Yuyuan Ying, Shiyu Hu, Qingru Sun, Guiyuan Lv & Jianli Gao. (2023) Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application. Molecules 28:8, pages 3539.
Crossref
Fahmida Rasha, Subhojit Paul, Tracey G. Simon & Yujin Hoshida. (2022) Hepatocellular Carcinoma Chemoprevention with Generic Agents. Seminars in Liver Disease 42:04, pages 501-513.
Crossref
Juqiang Zhang, Hao Peng, Botian Wang, Lei Luo, Yuan Cheng, Guolin He, Yujun Tang & MingXin Pan. (2020) Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell. Journal of Gastrointestinal Surgery 25:7, pages 1770-1778.
Crossref
He Linye, Xia Zijing, Peng Wei, He Chao, Li Chuan & Wen Tianfu. (2021) Thymosin alpha-1 therapy improves postoperative survival after curative resection for solitary hepatitis B virus-related hepatocellular carcinoma. Medicine 100:20, pages e25749.
Crossref
Naoto Fujiwara, Scott L. Friedman, Nicolas Goossens & Yujin Hoshida. (2018) Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. Journal of Hepatology 68:3, pages 526-549.
Crossref
Xueliang Yang, Yunru Chen, Jian Zhang, Tiantian Tang, Ying Kong, Feng Ye, Xi Zhang, Xiaojing Liu & Shumei Lin. (2018) Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure. Experimental and Therapeutic Medicine.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.